We are live on ! Find out more
ADPT icon

Adaptive Biotechnologies
ADPT

219 hedge funds and large institutions have $4B invested in Adaptive Biotechnologies in 2021 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 84 increasing their positions, 63 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more call options, than puts

Call options by funds: $6.5M | Put options by funds: $4.11M

33% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 63

0.05% more ownership

Funds ownership: 83.68% → 83.73% (+0.05%)

5% less funds holding

Funds holding: 230 → 219 (-11)

16% less capital invested

Capital invested by funds: $4.8B → $4B (-$791M)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

24% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 29

Holders
219
Holders Change
-11
Holders Change %
-4.78%
% of All Funds
3.83%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
22
Increased
84
Reduced
63
Closed
29
Calls
$6.5M
Puts
$4.11M
Net Calls
+$2.39M
Net Calls Change
-$8.5M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$29.4M
2
AIM
ARK Investment Management
Florida
+$17.7M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$17.3M
4
BG
Bellevue Group
Switzerland
+$13.5M
5
BlackRock
BlackRock
New York
+$9.78M

Top Sellers

1
SM
SB Management
United Arab Emirates
-$50.7M
2
RSCM
Rock Springs Capital Management
Maryland
-$26.6M
3
KCM
Kornitzer Capital Management
Kansas
-$15.8M
4
MCMC
Matrix Capital Management Company
New Hampshire
-$8.23M
5
ZCI
Zevenbergen Capital Investments
Washington
-$8.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
Viking Global Investors
1
Viking Global Investors
Connecticut
$1.02B – – –
MCMC
2
Matrix Capital Management Company
New Hampshire
$393M -$8.23M -227,500 -2%
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$389M +$17.3M +479,331 +4%
Vanguard Group
4
Vanguard Group
Pennsylvania
$374M +$29.4M +813,014 +8%
BlackRock
5
BlackRock
New York
$190M +$9.78M +270,369 +5%
AIM
6
ARK Investment Management
Florida
$165M +$17.7M +489,444 +11%
Neuberger Berman Group
7
Neuberger Berman Group
New York
$76.5M +$1.87M +51,843 +2%
Massachusetts Financial Services
8
Massachusetts Financial Services
Massachusetts
$75.4M +$2.55M +70,410 +3%
Capital International Investors
9
Capital International Investors
California
$71.2M +$4.67M +129,116 +7%
Sumitomo Mitsui Trust Group
10
Sumitomo Mitsui Trust Group
Japan
$70.1M +$8.61M +238,060 +13%
GGHC
11
Gilder Gagnon Howe & Co
New York
$67M -$2.9M -80,237 -4%
NAMA
12
Nikko Asset Management Americas
New York
$66.8M +$8.87M +245,259 +14%
State Street
13
State Street
Massachusetts
$51.9M +$3.57M +98,837 +7%
Invesco
14
Invesco
Georgia
$51.4M -$727K -20,090 -1%
CC
15
Casdin Capital
New York
$48.9M – – –
Geode Capital Management
16
Geode Capital Management
Massachusetts
$47.3M +$8.06M +222,728 +19%
BG
17
Bellevue Group
Switzerland
$45.4M +$13.5M +373,671 +39%
Goldman Sachs
18
Goldman Sachs
New York
$43.2M -$3.88M -107,367 -8%
Lazard Asset Management
19
Lazard Asset Management
New York
$39.8M +$1.13M +31,222 +3%
TM
20
Tiger Management
New York
$37.9M – – –
TCM
21
TimesSquare Capital Management
New York
$36.4M -$333K -9,200 -0.9%
SIG
22
Senator Investment Group
New York
$34M – – –
Norges Bank
23
Norges Bank
Norway
$33M +$1.98M +54,830 +6%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$31.7M +$936K +25,869 +3%
Charles Schwab
25
Charles Schwab
California
$27.9M +$7.08M +195,751 +31%
1
2 3 4 5

ADPT Hedge Fund Activity: Q3 2021 in Review

219 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Adaptive Biotechnologies (ADPT) for Q3 2021, worth a combined $4B — down 16% from $4.8B a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of ADPT and 22 opened new positions — a net loss of 7 holders — while 63 trimmed existing stakes and 84 added.

The largest buyer was Vanguard Group, adding an estimated $29.4M. The largest seller was SB Management, exiting entirely with an estimated $50.7M sold.

  • 219 institutional investors held Adaptive Biotechnologies (ADPT) as of Q3 2021, down from 230 in Q2 2021.
  • Funds reported $4B of Adaptive Biotechnologies stock for Q3 2021, down 16% quarter-over-quarter.
  • 22 funds opened new Adaptive Biotechnologies positions in Q3 2021 and 29 closed out, a net change of -7 holders.
  • The largest Adaptive Biotechnologies buyer in Q3 2021 was Vanguard Group, an estimated $29.4M added.
  • The largest Adaptive Biotechnologies seller in Q3 2021 was SB Management, an estimated $50.7M sold.

Based on aggregated 13F filings for Q3 2021.